
Alert: New Earnings Report (3/3/25)-TG Therapeutics Inc (NASDAQ: TGTX).
TG Therapeutics Inc (NASDAQ: TGTX) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.16 versus a loss $-0.10 for the same period a year ago — a decline of -260%. For […]